Reports can be incomplete, duplicated, influenced by other products, or missing reliable exposure details
Serious Allergic Reactions: Stop using tirzepatide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy
Tafani M, Sansone L, Limana F, Arcangeli T, De Santis E, Polese M, et al
[55], showed that rats, orally receiving radiolabeled LC, metabolized it to -butyrobetaine (up to 31% of the administered dose, present primary in feces) and TMAO (up to 23% of the administered dose, present primary in urine)
[15] Tirzepatide is currently licensed in the UK for type 2 diabetes (as Mounjaro)